arrow
E

Elba Llop

yokohama city university
H指数:33
被引数:4,932

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement

代谢功能障碍相关脂肪性肝病且FIB-4与肝硬度测量结果不一致患者的组织学严重程度和肝脏结局

2026-01-011
PRE
Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver disease

振动控制瞬时弹性成像与组织学在预测代谢功能障碍相关脂肪性肝病相关事件中的头对头比较

2025-12-010
PRE
Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD

心血管-肾脏-代谢综合征与MASLD患者肝纤维化进展及肝脏相关事件的风险

2025-12-010
PRE
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD

使用非侵入性检测预测当代多中心队列中cACLD患者的肝功能失代偿

2025-11-040
PRE
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD

长期血糖控制与肝硬度进展及肝脏相关事件风险的关系 (MASLD)

2025-10-100
PRE
Association between longitudinal weight change and clinical outcome in individuals with MASLD

MASLD个体中纵向体重变化与临床结局的关联

2025-10-012
PRE
Erratum to ‘Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis’ [J Hepatol 83 (2025) 70–80]

勘误:‘Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis’ [J Hepatol 83 (2025) 70–80]

2025-09-050
PRE
Effect of Hypertension on Long-term Adverse Clinical Outcomes and Liver Fibrosis Progression in MASLD

高血压对长期不良临床结局及MASLD患者肝纤维化进展的影响

2025-08-230
PRE
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD

纤维化标志物的纵向变化:监测MASLD的僵硬/纤维化进展和预后结局

2025-07-240
PRE
Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study

利伐沙班预防肝硬化门静脉高压并发症:CIRROXABAN研究

2025-07-190
PRE
A novel risk prediction model for hepatocellular carcinoma in MASLD: A multinational, multicenter cohort study

一种新型MASLD相关肝细胞癌风险预测模型:一项跨国、多中心队列研究

2025-07-100
PRE
From “Burnt-Out” to “Burning-Out”: Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction–Associated Steatotic Liver Disease From a Dynamic Perspective

从“耗竭”到“燃烧”:从动态角度捕捉代谢功能障碍相关脂肪性肝病晚期患者肝脏脂肪的流失

2025-03-180
PRE
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial

内镜袖状胃成形术联合生活方式干预在代谢功能障碍相关脂肪性肝炎患者中的应用:一项多中心、假手术对照、随机试验

2024-12-160
PRE
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
2024-12-012
PRE
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

SARS-CoV-2疫苗接种对血管性肝病患者的影响: 来自VALDIG多中心研究的观察

2024-12-010
OAAI
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

肝静脉压力梯度预测MASLD患者肝功能失代偿和肝脏相关死亡率的风险

2024-11-014
OAAI
Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure
2024-10-010
PRE
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

振动控制瞬时弹性成像评分预测脂肪性肝病的肝脏相关事件

2024-04-1628
OA